Fig. 1From: Aberrant methylation of cell-free circulating DNA in plasma predicts poor outcome in diffuse large B cell lymphomaDNA concentrations in the control plasma samples and the plasma samples taken at time of DLBCL diagnosis and following treatmentBack to article page